Cross-sectional analysis between prostate volumes and serum sex hormones in Japanese men attending a urological clinic

References

• Berry S, Coffey D, Walsh P, Ewing L. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474–9
   PubMed Web of Science ®Google Scholar
• Carson C, Rittmaster R. The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 2003;61:2–7
   PubMed Web of Science ®Google Scholar
• Lagiou P, Montzoros C, Tzonou A, et al. Serum steroids in relation to benign prostatic hyperplasia. Oncology 1997;54:497–501
   PubMed Web of Science ®Google Scholar
• Stege R, Carlstrom K. Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia. J Steroid Biochem Mol Biol 1992;42:357–62
   PubMed Web of Science ®Google Scholar
• Partin A, Oesterling J, Epstein J, et al. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol 1991;145:405–9
   PubMed Web of Science ®Google Scholar
• Roberts R, Jacobson D, Rhodes T, et al. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 2004;61:124–31
   PubMed Web of Science ®Google Scholar
• Suzuki K, Inaba S, Takeuchi H, et al. Endocrine environment of benign prostatic hyperplasia-Relationship of sex steroid hormone levels with age and the size of the prostate. Jpn J Urol 1992;83:664–71
   PubMedGoogle Scholar
• Vermeulen A, Kaufman J, Goemaere S, van Pottelberg I. Estradiol in elderly men. Aging Male 2002;5:98–102
   PubMedGoogle Scholar
• Finkelstein J, Lee H, Sherri-Ann M, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013;369:1011–21
   PubMed Web of Science ®Google Scholar
• Ho C, Nanda J, Chapman K, Habib F. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen. J Endocrinol 2008;197:483–91
   PubMed Web of Science ®Google Scholar
• Nomoto K, Arita S, Yonei Y. Development of a model of functional endocrine age in Japanese people – serum dehydroepiandrosterone-sulfate (DHEA-s) concentration as an index of aging. Anti-Aging Med 2011;8:69–74
   Google Scholar
• Brochu M, Belanger A. Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia. Prostate 1987;11:33–40
   PubMed Web of Science ®Google Scholar
• Schatzl G, Brossner C, Schmid S, et al. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. Urology 2000;55:397–402
   PubMed Web of Science ®Google Scholar
• Liu C, Huang S, Li W, et al. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology 2007;70:677–80
   PubMed Web of Science ®Google Scholar
• Terris M, Stamey T. Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984–7
   PubMed Web of Science ®Google Scholar
• Homma Y, Ishizuka O, Ozono S, et al. Clinical guideline for benign prostatic hyperplasia. Tokyo, Japan: RichHill Medical Inc., The Japanese Urological Association; 2011
   Google Scholar
• Nukui M. Epidemiological study on diet, smoking and alcohol drinking in the relationship to prostatic weight. Jpn J Urol 1997;88:950–6
   PubMedGoogle Scholar
• Masumori N, Tsukamoto T, Kumamoto Y, et al. Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol 1996;155:1324–7
   PubMed Web of Science ®Google Scholar
• Sugimura Y. Basic study in the natural history of benign prostatic hyperplasia: biology of prostatic growth. Jpn J Urol 1996;87:721–39
   PubMedGoogle Scholar
• Isaacs J, Coffey D. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989;2:33–50
   PubMedGoogle Scholar
• Harman S, Metter E, Tobin J, et al. Longitudinal effects of aging on total and free testosterone level in healthy men. J Clin Endocrinol Metab 2001;86:724–31
   PubMed Web of Science ®Google Scholar
• Marberger M, Roehrborn C, Marks L, et al. Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia. J Clin Endocrinol Metab 2006;91:1323–8
   PubMed Web of Science ®Google Scholar
• Karazindiyanoğlu S, Selahittin Ç. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 2008;11:146–9
   PubMed Web of Science ®Google Scholar
• Meuleman E, Legros J, Bouloux P, et al. Effects of long-term oral testosterone undecanoate therapy on urinary symptoms: data from a 1-year, placebo-controlled, dose-ranging trial in aging men with symptomatic hypogonadism. Aging Male 2015;18:157–63
   PubMed Web of Science ®Google Scholar
• Yassin A, Nettleship J, Talib R, et al. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters. Aging Male 2015;8:1–6
   Google Scholar
• Walsh P, Wilson J. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest 1976;57:1093–7
   PubMed Web of Science ®Google Scholar
• Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5α-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 1992;77:375–81
   Web of Science ®Google Scholar
• Iwamoto T, Yanase T, Koh E, et al. Reference range of serum total and free testosterone in Japanese male adults. Jpn J Urol 2004;95:751–60
   PubMedGoogle Scholar
• Algarté-Génin M, Cussenot O, Costa P. Prevention of prostate cancer by androgens: experimental paradox or clinical reality. Eur Urol 2004;46:285–95
   PubMed Web of Science ®Google Scholar